-

$undefined

N/A

(N/A)

OKYO Pharma NASDAQ:OKYO OKYO Pharma is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of inflammatory eye diseases and chronic pain. The company's main focus is the clinical development of OK-101 to treat dry eye disease (DED).

Location: London, United Kingdom | Website: https://okyopharma.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

36.85M

Cash

987.2K

Avg Qtr Burn

-734.8K

Short % of Float

1.39%

Insider Ownership

27.61%

Institutional Own.

3.03%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date